CNTF Receptors: Neuromuscular Protection/Repair In Vivo
CNTF Receptors: Neuromuscular Protection/Repair In Vivo
批准号:
7283750
负责人:
Alexander John MacLennan
金额:
$33.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-10 至 2010-04-30
关键词:
AdultAdverse effectsAffectAxonBungarotoxinsCandidate Disease GeneCell CountCellsCessation of lifeCholinergic AgentsCiliary Neurotrophic FactorCiliary Neurotrophic Factor ReceptorConfocal MicroscopyDataDefectDependenceDependovirusDisruptionFaceFacial nerve nucleusGene ExpressionGenesGeneticImmunohistochemistryImpairmentIn Situ HybridizationIn VitroInjection of therapeutic agentKnock-outKnockout MiceLanguageLesionLigand BindingLiteratureLocalizedMaintenanceMeasurementMechanicsMetalcaptaseMicroarray AnalysisMiningModelingMotorMotor NeuronsMusMuscleMutationNerveNeuromuscular DiseasesNeuromuscular JunctionPerinatalPeripheral NervesPeripheral nerve injuryPhenotypePlayPropertyProteinsReceptor SignalingRecoveryReporter GenesReportingRoleSeriesSignal TransductionSignaling ProteinSiteSkeletal MuscleSpinal CordStaining methodStainsSystemTechniquesTherapeuticTissuesToxinTraumaViralbasecholinergiccresyl violetdesignenhancing factorgray matterin vivoknowledge of resultsmature animalneuromuscular systemneuroprotectionnovelreceptorreceptor functionrecombinaserepairedsciatic nerve lesiontool
中文摘要
描述(由申请人提供):一些证据表明内源性睫状神经营养因子(CNTF)受体信号传导可能促进神经肌肉的保护和修复。因此,适当靶向CNTF受体信号可以通过适当增强这些自然进化的机制来选择性地抵消神经肌肉疾病的破坏性影响。不幸的是,目前对成人内源性CNTF受体功能的了解非常有限,因为体内受体阻断(通过破坏关键的CNTF受体a [CNTFRa]基因)会导致围产期死亡。为了克服这个问题,我们将使用Cre/lox技术选择性地破坏CNTFRa基因。特异性目的1将研究CNTF受体信号传导对成年运动神经元的存活、保护和表型维持的贡献。研究人员将通过以下方法破坏“floxed”CNTFRa小鼠面部运动神经元中的CNTFRa基因:1)向面核立体定向注射一种引导Cre重组酶(Cre)表达的腺相关病毒;2)构建一种能够暂时控制Cre活性诱导的基因。初步数据表明,CNTFRa在成人运动神经元存活中起着重要的体内作用。我们将通过报告基因、免疫组织化学和体视细胞计数定量表征这一功能,并确定是否需要损伤来激活这一神经保护系统(如初步数据所示),如果需要,则需要何种形式的损伤。此外,报告基因和免疫组织化学将用于确定CNTF受体信号传导是否维持体内运动神经元胆碱能表型。最后,通过原位杂交和免疫组织化学鉴定可能参与神经保护的信号蛋白。特异性目标2将定义骨骼肌CNTFRa在神经肌肉保护和修复中的作用。来自骨骼肌特异性Cre表达的固定CNTFRa小鼠的初步数据显示,周围神经损伤后,肌肉CNTFRa是正常运动恢复所必需的。我们将通过“足迹”分析来表征这种功能缺陷,并通过量化来确定潜在的细胞机制:1)神经肌肉连接形成,2)运动神经元存活和胆碱能表型,以及3)肌肉收缩性。此外,基于stat3的免疫组织化学将用于定位神经病变后肌肉cntfr依赖信号的细胞部位。此外,神经病变后肌肉和脊髓腹侧灰质的微阵列分析将用于鉴定可能参与关键CNTF受体信号传导的新的候选基因。与外行语言的相关性:我们将确定小鼠天然CNTF受体信号如何保护和修复成人神经肌肉系统。由此产生的知识应该有助于设计治疗方法,选择性地增强适当的CNTF受体信号,从而有效地治疗神经肌肉疾病,同时避免副作用。
英文摘要
DESCRIPTION (provided by applicant): Several lines of evidence suggest that endogenous ciliary neurotrophic factor (CNTF) receptor signaling may promote neuromuscular protection and repair. Thus, proper targeting of CNTF receptor signaling may selectively counteract the devastating effects of neuromuscular disorders by appropriately enhancing these naturally evolved mechanisms. Unfortunately, current understanding of endogenous CNTF receptor function in the adult is extremely limited because blockage of the receptor in vivo (through disruption of the critical CNTF receptor a [CNTFRa] gene) leads to perinatal death. To overcome this problem, we will use Cre/lox techniques to selectively disrupt the CNTFRa gene. Specific Aim 1 will examine the contribution of CNTF receptor signaling to the survival, protection and phenotype maintenance of adult motor neurons. The CNTFRa gene will be disrupted in facial motor neurons of "floxed" CNTFRa mice with: 1) stereotaxic injection of the facial nucleus with an adeno-associated virus that directs Cre recombinase (Cre) expression and 2) a gene construct enabling temporally controlled induction of Cre activity. Preliminary data indicate an essential in vivo role for CNTFRa in adult motor neuron survival. We will quantitatively characterize this function with reporter genes, immunohistochemistry and stereological cell counting and also determine whether insult is required to activate this neuroprotective system (as preliminary data suggest), and if so, what forms of insult. In addition, a reporter gene and immunohistochemistry will be used to determine whether CNTF receptor signaling maintains motor neuron cholinergic phenotype in vivo. Finally, signaling proteins potentially involved in the neuroprotection will be identified through in situ hybridization and immunohistochemistry. Specific Aim 2 will define the role of skeletal muscle CNTFRa in neuromuscular protection and repair. Preliminary data from floxed CNTFRa mice with skeletal muscle specific Cre expression reveal that muscle CNTFRa is required for normal motor recovery following peripheral nerve lesion. We will characterize this functional deficit with "footprint" analysis and identify the underlying cellular mechanisms by quantifying: 1) neuromuscular junction formation, 2) motor neuron survival and cholinergic phenotype, and 3) muscle contractility. In addition, STAT3-based immunohistochemistry will be used to localize cellular sites of muscle-CNTFRa-dependent signaling after nerve lesion. Moreover, microarray analysis of muscle and spinal cord ventral grey matter following nerve lesion will be used to identify novel candidate genes potentially involved in the critical CNTF receptor signaling. Relevance in lay language: We will determine how natural CNTF receptor signaling in mice protects and repairs the adult neuromuscular system. The resulting knowledge should facilitate the design of therapeutics which selectively enhance the appropriate CNTF receptor signaling and thereby effectively treat neuromuscular disease while avoiding side effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene Therapy Targeting of CNTFRalpha and CLC in Muscle to Treat ALS
-
批准号:10427242
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2019
-
负责人:Alexander John MacLennan
-
依托单位:
Gene Therapy Targeting of CNTFRalpha and CLC in Muscle to Treat ALS
-
批准号:10017338
-
项目类别:
-
资助金额:$41.79万
-
财政年份:2019
-
负责人:Alexander John MacLennan
-
依托单位:
Gene Therapy Targeting of CNTFRalpha and CLC in Muscle to Treat ALS
-
批准号:10171631
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2019
-
负责人:Alexander John MacLennan
-
依托单位:
Gene Therapy Targeting of CNTFRalpha and CLC in Muscle to Treat ALS
-
批准号:10634588
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2019
-
负责人:Alexander John MacLennan
-
依托单位:
Endogenous CNTF receptors and adult, in vivo neurogenesis
-
批准号:8282856
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2009
-
负责人:Alexander John MacLennan
-
依托单位:
Endogenous CNTF receptors and adult, in vivo neurogenesis
-
批准号:8084123
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2009
-
负责人:Alexander John MacLennan
-
依托单位:
Endogenous CNTF receptors and adult, in vivo neurogenesis
-
批准号:7698608
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2009
-
负责人:Alexander John MacLennan
-
依托单位:
Endogenous CNTF receptors and adult, in vivo neurogenesis
-
批准号:8488497
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2009
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF Receptors: Neuromuscular Protection/Repair In Vivo
-
批准号:7100043
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2006
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF Receptors: Neuromuscular Protection/Repair In Vivo
-
批准号:7613407
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2006
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF Receptors: Neuromuscular Protection/Repair In Vivo
-
批准号:7414357
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2006
-
负责人:Alexander John MacLennan
-
依托单位:
CILIARY NEUROTROPHIC FACTOR RECEPTORS AND NEUROPROTECTIO
-
批准号:2899589
-
项目类别:
-
资助金额:$19.71万
-
财政年份:1999
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTORS AND NEUROPROTECTION AFTER BRAIN TRAUMA
-
批准号:6401832
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1999
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTORS AND NEUROPROTECTION AFTER BRAIN TRAUMA
-
批准号:6394227
-
项目类别:
-
资助金额:$21.82万
-
财政年份:1999
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTORS AND NEUROPROTECTION AFTER BRAIN TRAUMA
-
批准号:6540164
-
项目类别:
-
资助金额:$22.47万
-
财政年份:1999
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTOR ALPHA REGULATION AND FUNCTION
-
批准号:2038307
-
项目类别:
-
资助金额:$17.3万
-
财政年份:1997
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTOR ALPHA REGULATION AND FUNCTION
-
批准号:6187302
-
项目类别:
-
资助金额:$6.13万
-
财政年份:1997
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTOR ALPHA REGULATION AND FUNCTION
-
批准号:2714599
-
项目类别:
-
资助金额:$16.0万
-
财政年份:1997
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTOR ALPHA REGULATION AND FUNCTION
-
批准号:6401831
-
项目类别:
-
资助金额:$10.85万
-
财政年份:1997
-
负责人:Alexander John MacLennan
-
依托单位:
CNTF RECEPTOR ALPHA REGULATION AND FUNCTION
-
批准号:6393798
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1997
-
负责人:Alexander John MacLennan
-
依托单位:
海外基金